General Information of the Compound
Compound ID
CP0430190
Compound Name
1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole
    Show/Hide
Synonyms
1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole
CHEMBL180826
    Show/Hide
Structure
Formula
C19H20N2O2S
Molecular Weight
340.448
Canonical SMILES
O=S(=O)(c1ccccc1)n1cc(C2CCNCC2)c2ccccc12
    Show/Hide
InChI
InChI=1S/C19H20N2O2S/c22-24(23,16-6-2-1-3-7-16)21-14-18(15-10-12-20-13-11-15)17-8-4-5-9-19(17)21/h1-9,14-15,20H,10-13H2
    Show/Hide
InChIKey
CACLUIQWYMWMBO-UHFFFAOYSA-N
Physicochemical Property
logP
3.3453
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
51.1
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44388931
ChEMBL ID
CHEMBL180826
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  2
1
IC50 = 19.5 nM
   TI
   LI
   LO
   TS
2
Ki = 12 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole )
Drug Name 1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole
Target(s)
5-HT 6 receptor (HTR6)
Inhibitor